EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deletion of SPI1 in microglia exacerbates amyloid pathology by impairing microglial response in Alzheimer’s disease models

Byungwook Kim, Mason Douglas Tate, Hande Karahan, H R Sagara Wijeratne, Ahmad Daniel Sharify, Selena S Wang, Justin R Kim, Md Mamun Al-Amin, Kelly Hartigan, Sunwoo Chung, Luke Child Dabin, Dominic J Acri und 4 weitere

Neuron · 2026-08 · 114 (15) · 2741-2758.e6

DOI: 10.1016/j.neuron.2026.03.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuron, 2026-08. Verfasst von Byungwook Kim und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical & Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Stark Neuroscience Research Institute…. Hauptthemen laut MEDLINE: Microglia, Alzheimer Disease, Trans-Activators, Proto-Oncogene Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIGMS NIH HHS, Indiana University Foundation Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent human genetic studies have highlighted the potential role of microglial genes and their regulatory functions in the pathogenesis of Alzheimer's disease (AD). The transcription factor PU.1 (encoded by SPI1) is expressed mainly in microglia in the central nervous system and has been reported to be a genetic risk factor for AD. However, the role of microglial SPI1 in AD etiology is still poorly understood. Here, we demonstrate that the selective deletion of Spi1 in microglia exacerbates AD-related pathologies in an amyloid mouse model. Specifically, microglial Spi1 deletion increases amyloid deposition, gliosis, and dystrophic neurites while decreasing the microglial response to plaques. By combining proteomics and functional analyses, we reveal that the loss of microglial Spi1 impairs phagocytosis through Syk, Lyn, and Fcgr1. Furthermore, directly activating these genes rescues the impaired amyloid-beta (Aβ) uptake caused by Spi1 knockdown, unveiling the potential mechanism of SPI1 in amyloid pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaAlzheimer DiseaseTrans-ActivatorsProto-Oncogene ProteinsPlaque, AmyloidAnimalsProto-Oncogene Protein Spi-1MiceDisease Models, AnimalAmyloid beta-PeptidesMice, TransgenicPhagocytosis

Stichwörter der Autor:innen

Alzheimer’s diseaseFcgr1LynPU.1SPI1Sykamyloidamyloidosismicrogliaphagocytosis

Substanzen

Proto-Oncogene Protein Spi-1Trans-ActivatorsProto-Oncogene ProteinsAmyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Medical & Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Stark Neuroscience Research Institute, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
  • Department of Medical & Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Stark Neuroscience Research Institute, Indiana University School of Medicine, Indianapolis, IN 46202, USA;…
  • Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapo…

Förderung

  • NIA NIH HHS
  • NIGMS NIH HHS
  • Indiana University Foundation Inc
  • Alzheimer's Association
  • National Institute on Aging
  • Indiana University
  • National Institutes of Health

Zitieren

APA

Kim, B., Tate, M. D., Karahan, H., Wijeratne, H. R. S., Sharify, A. D., Wang, S. S., Kim, J. R., Al-Amin, M. M., Hartigan, K., Chung, S., Dabin, L. C., Acri, D. J., Doud, E. H., John, S. K., Mosley, A. L., & Kim, J. (2026). Deletion of SPI1 in microglia exacerbates amyloid pathology by impairing microglial response in Alzheimer’s disease models. Neuron, 114(15), 2741-2758.e6. https://doi.org/10.1016/j.neuron.2026.03.011

Vancouver

Kim B, Tate MD, Karahan H, Wijeratne HRS, Sharify AD, Wang SS, et al. Deletion of SPI1 in microglia exacerbates amyloid pathology by impairing microglial response in Alzheimer’s disease models. Neuron. 2026;114(15):2741-2758.e6. doi:10.1016/j.neuron.2026.03.011

BibTeX
@article{Kim2026,
  author = {Kim, Byungwook and Tate, Mason Douglas and Karahan, Hande and Wijeratne, H R Sagara and Sharify, Ahmad Daniel and Wang, Selena S and Kim, Justin R and Al-Amin, Md Mamun and Hartigan, Kelly and Chung, Sunwoo and Dabin, Luke Child and Acri, Dominic J and Doud, Emma H and John, Sutha K and Mosley, Amber L and Kim, Jungsu},
  title = {Deletion of SPI1 in microglia exacerbates amyloid pathology by impairing microglial response in Alzheimer’s disease models},
  journal = {Neuron},
  year = {2026},
  volume = {114},
  number = {15},
  pages = {2741--2758.e6},
  doi = {10.1016/j.neuron.2026.03.011}
}
Kostenlos starten →